3,5-Di-tert-butyl-4-hydroxyphenylpropionic acid

Independent reference data for 3,5-Di-tert-butyl-4-hydroxyphenylpropionic acid (CAS 20170-32-5), compiled from public chemistry databases.

Registry identifiers across databases

Computed descriptors

Documented uses on record

Benzenepropanoic acid, 3,5-bis(1,1-dimethylethyl)-4-hydroxy-: ACTIVEAgents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.

Synonyms and trade names

20170-32-5; Fenozan; 3,5-Bis(1,1-dimethylethyl)-4-hydroxybenzenepropanoic acid; Benzenepropanoic acid, 3,5-bis(1,1-dimethylethyl)-4-hydroxy-; X6G09G700F; DTXSID2066561; phenozan; fenozan-K; potassium fenozan; potassium phenosan; RefChem:491484; DTXCID0036211; 3-(3',5'-di-tert-butyl-4'-hydroxyphenyl)propionic acid; beta-(4-hydroxy-3,5-di-tert-butyl)phenylpropionic acid; beta-(4-hydroxy-3,5-di-tert-butylphenyl)propionic acid; beta-(4-hydroxy-3,5-di-tertbutylphenyl) propionic acid

Regulatory listings held on file

Regulatory & Food Contact	FDA Cumulative Estimated Daily Intake (CEDI): FCS
GHS notification summary	75.9% (104 / 137)

GHS hazard classification

GHS notification summary	75.9% (104 / 137)
Reported hazard statements	H302 (19%)

This chemical does not meet GHS hazard criteria for 75.9% (104 of 137) of all reports.

H302 (19%): Harmful if swallowed [Warning Acute toxicity, oral]

What the public record says

3,5-Di-tert-butyl-4-hydroxyphenylpropionic acid · CAS 20170-32-5 · C17H26O3. UNII X6G09G700F.

Source: PubChem / Wikidata; the batch COA governs where values differ.